Keyphrases
Disease-free Survival
100%
Type I Endometrial Carcinoma
100%
Mismatch Repair Protein Deficiency
100%
Deficient Mismatch Repair (dMMR)
100%
Recurrence Risk
75%
Mismatch Repair
75%
Histological Grade
50%
Mismatch Repair Proteins
50%
Paraffin Blocks
25%
Medical Records
25%
Independent Risk Factors
25%
Immunohistochemistry
25%
Cohort Design
25%
January 2017
25%
Hazard Ratio
25%
Protein Level
25%
Tumor Stage
25%
High Stage
25%
Endometrial Carcinoma
25%
Historical Cohort
25%
MSH2
25%
MLH1
25%
Medicine and Dentistry
Disease Free Survival
100%
Mismatch Repair Protein
100%
Endometrium Carcinoma
100%
Protein Deficiency
100%
Recurrent Disease
60%
DNA Mismatch Repair
60%
Observational Study
20%
Medical Record
20%
Immunohistochemistry
20%
Hazard Ratio
20%
Cancer Staging
20%
MutL Protein Homolog 1
20%
DNA Mismatch Repair Protein MSH2
20%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Free Survival
100%
Mismatch Repair Protein
100%
Protein Deficiency
100%
Endometrium Carcinoma
100%
Recurrent Disease
60%
Observational Study
20%
Cancer Staging
20%
MutL Protein Homolog 1
20%
DNA Mismatch Repair Protein MSH2
20%
Biochemistry, Genetics and Molecular Biology
Disease Free Survival
100%
DNA Mismatch Repair
100%
Medical Record
16%
Observational Study
16%
Cancer Staging
16%
MLH1
16%
MSH2
16%
Immunology and Microbiology
Disease Free Survival
100%
Mismatch Repair
100%
Medical Record
16%
Cancer Staging
16%